"42920" . "Buzrla, Petr" . . "\u017Dmol\u00EDkov\u00E1, Jana" . . "0042-773X" . . "Svoboda, Pavel" . . "Uv\u00EDrov\u00E1, Magdalena" . "Urbanovsk\u00E1, Irena" . "5-6" . "Kupka, Tom\u00E1\u0161" . "10"^^ . . . "Risk factors and progression predictors of Barrett\u00B4s oesophagus to adenocarcinoma"@en . "RIV/61988987:17110/14:A1501BM1!RIV15-MSM-17110___" . "10"^^ . "S" . "D\u00EDt\u011B, Petr" . "7"^^ . . "60" . "CZ - \u010Cesk\u00E1 republika" . . . . "Vnit\u0159n\u00ED l\u00E9ka\u0159stv\u00ED" . "Dvo\u0159\u00E1\u010Dkov\u00E1, Jana" . "Rizikov\u00E9 faktory a prediktory progrese Barrettova j\u00EDcnu do adenokarcinomu"@cs . "Rizikov\u00E9 faktory a prediktory progrese Barrettova j\u00EDcnu do adenokarcinomu" . . . . . . . "Refluxn\u00ED choroba j\u00EDcnu je pom\u011Brn\u011B \u010Dast\u00E9 onemocn\u011Bn\u00ED, refluxn\u00EDmi pot\u00ED\u017Eemi str\u00E1d\u00E1 b\u011Bhem \u017Eivota a\u017E 40 % populace. Na\u0161t\u011Bst\u00ED asi polovina nemocn\u00FDch, kte\u0159\u00ED jsou vy\u0161et\u0159eni pro jasn\u00E9 obt\u00ED\u017Ee, nevykazuje makroskopick\u00E9 po\u0161kozen\u00ED sliznice j\u00EDcnu a jen pom\u011Brn\u011B mal\u00E9 procento pacient\u016F m\u00E1 z\u00E1va\u017En\u00FD endoskopick\u00FD n\u00E1lez - Barrett\u016Fv j\u00EDcen (10 %). Jedn\u00E1 se o z\u00E1va\u017Enou komplikaci - prekancer\u00F3zu s 30kr\u00E1t vy\u0161\u0161\u00EDm rizikem vzniku adenokarcinomu ne\u017E u pacient\u016F bez Barrettova j\u00EDcnu. \u010Cl\u00E1nek pojedn\u00E1v\u00E1 o rizikov\u00FDch faktorech a prediktorech progrese Barrettova j\u00EDcnu do adenokarcinomu. Mu\u017Esk\u00E9 pohlav\u00ED, b\u00EDl\u00E1 rasa, refluxn\u00ED choroba j\u00EDcnu, Barrett\u016Fv j\u00EDcen a obezita jsou rizikov\u00FDmi faktory pro adenokarcinom j\u00EDcnu. Znalost t\u011Bchto faktor\u016F se m\u016F\u017Ee uplatnit v prevenci vzniku adenokarcinomu j\u00EDcnu, proto\u017Ee pr\u00E1v\u011B selekc\u00ED pacient\u016F na z\u00E1klad\u011B rizik a prediktor\u016F progrese Barrettova j\u00EDcnu do dysplazie a adenokarcinomu lze vytvo\u0159it \u00FA\u010Deln\u011Bj\u0161\u00ED a cost-efektivn\u011Bj\u0161\u00ED dispenz\u00E1rn\u00ED programy."@cs . . "Klva\u0148a, Pavel" . "Bojkov\u00E1, Martina" . "[304D05688ADC]" . "Rizikov\u00E9 faktory a prediktory progrese Barrettova j\u00EDcnu do adenokarcinomu" . "Refluxn\u00ED choroba j\u00EDcnu je pom\u011Brn\u011B \u010Dast\u00E9 onemocn\u011Bn\u00ED, refluxn\u00EDmi pot\u00ED\u017Eemi str\u00E1d\u00E1 b\u011Bhem \u017Eivota a\u017E 40 % populace. Na\u0161t\u011Bst\u00ED asi polovina nemocn\u00FDch, kte\u0159\u00ED jsou vy\u0161et\u0159eni pro jasn\u00E9 obt\u00ED\u017Ee, nevykazuje makroskopick\u00E9 po\u0161kozen\u00ED sliznice j\u00EDcnu a jen pom\u011Brn\u011B mal\u00E9 procento pacient\u016F m\u00E1 z\u00E1va\u017En\u00FD endoskopick\u00FD n\u00E1lez - Barrett\u016Fv j\u00EDcen (10 %). Jedn\u00E1 se o z\u00E1va\u017Enou komplikaci - prekancer\u00F3zu s 30kr\u00E1t vy\u0161\u0161\u00EDm rizikem vzniku adenokarcinomu ne\u017E u pacient\u016F bez Barrettova j\u00EDcnu. \u010Cl\u00E1nek pojedn\u00E1v\u00E1 o rizikov\u00FDch faktorech a prediktorech progrese Barrettova j\u00EDcnu do adenokarcinomu. Mu\u017Esk\u00E9 pohlav\u00ED, b\u00EDl\u00E1 rasa, refluxn\u00ED choroba j\u00EDcnu, Barrett\u016Fv j\u00EDcen a obezita jsou rizikov\u00FDmi faktory pro adenokarcinom j\u00EDcnu. Znalost t\u011Bchto faktor\u016F se m\u016F\u017Ee uplatnit v prevenci vzniku adenokarcinomu j\u00EDcnu, proto\u017Ee pr\u00E1v\u011B selekc\u00ED pacient\u016F na z\u00E1klad\u011B rizik a prediktor\u016F progrese Barrettova j\u00EDcnu do dysplazie a adenokarcinomu lze vytvo\u0159it \u00FA\u010Deln\u011Bj\u0161\u00ED a cost-efektivn\u011Bj\u0161\u00ED dispenz\u00E1rn\u00ED programy." . . . "17110" . "Risk factors and progression predictors of Barrett\u00B4s oesophagus to adenocarcinoma"@en . "RIV/61988987:17110/14:A1501BM1" . "aetiology; Barrett's oesophagus; oesophageal adenocarcinoma; reflux"@en . . "Rizikov\u00E9 faktory a prediktory progrese Barrettova j\u00EDcnu do adenokarcinomu"@cs . . "Gastroesophageal reflux disease is a quite common disorder, and the condition affects some 40 per cent of population in the course of their lifetime. Fortunately, about half of the patients examined due to clear symptoms do not manifest macroscopic damage of the oesophageal mucosa, and serious endoscopic findings (Barrett's oesophagus) are observed in only a small percentage of patients (10%). Barrett's oesophagus is a serious complication - precancerous condition with a 30-fold higher risk of development of oesophageal adenocarcinoma when compared with patients without this condition. The article presents risk factors and predictors of progression of the Barrett's oesophagus into the stage of adenocarcinoma. The main risk factors associated with oesophageal adenocarcinoma are male sex, white race, gastroesophageal reflux."@en . . . .